Teva Pharmaceuticals USA Inc recalls Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distr
Recalled June 15, 2022 · FDA recall D-0988-2022 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing · FDA Class III
Units
3109 cartons
Sold at
Product was distributed nationwide in the US Market
Description
Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
Product
Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01
Manufacturer(s)
Teva Pharmaceuticals USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →